Search For Lab Tests Here

The Chlamydia trachomatis RNA TMA Urine Test detects genetic material of C. trachomatis using transcription-mediated amplification (TMA), a highly sensitive method for diagnosing infection. Doctors order this noninvasive urine test for patients with symptoms like discharge, pain, or burning urination, or for routine STD screening. Results help confirm infection, guide treatment, and prevent complications such as infertility, pelvic inflammatory disease, or transmission.

The Chlamydia/Neisseria gonorrhoeae RNA, TMA Urine Test screens for both chlamydia and gonorrhea infections by detecting RNA from these bacteria. Using advanced molecular technology, it offers high accuracy for diagnosing active infections. Doctors order this urine-based test to confirm infection, support early treatment, and protect sexual partners. It is an essential tool for sexual health screening, helping reduce long-term health risks and control STD spread.

The Chlamydia trachomatis IgM Antibody Test detects IgM antibodies produced during early immune response to C. trachomatis infection. IgM positivity can indicate recent or acute infection, making it useful for identifying new exposure. This test provides valuable diagnostic information for evaluating sexually transmitted infections, guiding management, and supporting early detection of reproductive or urogenital health risks.

Why pay $69 for Chlamydia & Gonorrhea urine test kit when you can experience the convenience and affordablity of a Chlamydia & Gonorrhea lab test with Ulta Lab Tests - compare now and save!

 The STD Urinary Tract Infection Panel is a targeted diagnostic tool designed to identify sexually transmitted infections (STIs) such as Chlamydia and Gonorrhea, alongside assessing overall urinary tract health through a Urinalysis Complete test. This panel facilitates the early detection of common STIs and urinary tract infections (UTIs), allowing for timely treatment and management.

 The STD Basic panel is a curated selection of tests aimed at detecting some of the most common sexually transmitted diseases (STDs). These tests employ various laboratory techniques to identify the presence of specific pathogens or the body's immune response to them. By providing insights into an individual's sexual health status, this panel plays a pivotal role in early detection, treatment, and prevention of further transmission of these infections.

 The STD Comprehensive panel offers a broad overview of an individual's sexual health by screening for several prevalent sexually transmitted diseases. This comprehensive approach ensures that both bacterial and viral infections are tested for, providing a detailed picture of potential risks and existing infections, many of which may be asymptomatic.

The Lymphogranuloma Venereum (LGV) Differentiation Antibody Panel uses micro-immunofluorescence (MIF) to measure IgG, IgA, and IgM antibodies to Chlamydia trachomatis (LGV L1 and non-LGV D–K) and related Chlamydiaspecies (C. pneumoniae and C. psittaci). It helps differentiate antibody patterns consistent with LGV versus other chlamydial exposures when cross-reactivity may complicate interpretation.

The Neisseria gonorrhoeae RNA TMA Urine Test detects gonorrhea infection by identifying bacterial RNA using transcription-mediated amplification. This highly sensitive urine test helps diagnose current gonorrhea infections, even in asymptomatic cases. Doctors use it for early detection, accurate diagnosis, and timely treatment to prevent complications. Results support effective STD management and help reduce the risk of transmission.

The Mycoplasma pneumoniae IgG IgM Antibodies Test detects antibodies to M. pneumoniae, a common cause of respiratory infections and “walking pneumonia.” IgM indicates recent or active infection, while IgG suggests past exposure or immunity. Doctors use this blood test to confirm diagnosis, distinguish between current and previous infection, and guide treatment. It is especially helpful for evaluating persistent cough, fever, or suspected atypical pneumonia.

The RPR (Monitor) with Reflex to Titer Test screens for syphilis by detecting antibodies to Treponema pallidum. If positive, a reflex titer determines antibody concentration to assess disease activity and treatment response. Doctors order this test to diagnose syphilis, monitor therapy, or check reinfection. Results provide essential information for managing active infection, confirming treatment success, and guiding follow-up care.

The Herpes 2 IgG Antibody Test detects IgG antibodies to HSV-2, the virus that most often causes genital herpes. IgG develops weeks after infection and remains for life, making this test valuable for confirming past exposure or infection history. Doctors order it for patients with genital sores, blisters, or concerns about herpes transmission. Results help confirm HSV-2 infection, guide treatment, and support counseling, prevention, and long-term care.

The RPR Test with Reflex to Titer and Confirmatory Testing screens for syphilis by detecting non-treponemal antibodies. If reactive, results are automatically followed by a titer to measure antibody concentration and confirmatory treponemal testing for accuracy. Doctors use this test to diagnose active or past syphilis, monitor treatment, or screen at-risk patients. Results provide vital insight into infection status, disease stage, and overall sexual health.

The Syphilis FTA-ABS Test (Fluorescent Treponemal Antibody Absorption) detects antibodies specific to Treponema pallidum, the bacteria that cause syphilis. Doctors use this confirmatory test after a positive screening to verify infection, even in late or latent stages. Results help distinguish syphilis from false positives, guiding diagnosis, treatment, and follow-up. This test is essential for accurate detection and long-term monitoring of syphilis.

The Syphilis Test is an RPR Test with Reflex to Titer and Confirmatory Testing that screens for antibodies to Treponema pallidum. If reactive, additional testing confirms infection and measures antibody levels to assess disease activity. Doctors use this blood test to diagnose syphilis, determine stage, and monitor treatment response. It is widely used in STD screening, prenatal care, and early detection to prevent complications and transmission.

The Culture Urine Routine Test detects and identifies bacteria or yeast in urine that cause urinary tract infections (UTIs). By growing microorganisms in a lab, this test determines the type of infection and guides effective treatment. Doctors use it to evaluate symptoms such as painful urination, frequent urges, or fever and to monitor recurrent UTIs. Results provide critical insight for diagnosis, antibiotic selection, and urinary health management.

The Herpes 1 and 2 Test uses type-specific HSV-1/HSV-2 IgG to assess past infection and differentiate exposure to each virus. It is useful for evaluating recurrent lesions, screening asymptomatic partners, and documenting baseline status for clinical management. Because IgG can take 2–12 weeks to develop, early negatives may need repeat testing; HSV-2 reactive results reflex to an inhibition assay to verify specificity and reduce cross-reactivity.

The Syphilis RPR Test screens for syphilis by detecting nonspecific antibodies produced in response to Treponema pallidum. If positive, a reflex titer is performed to measure antibody levels and monitor disease activity. Doctors use this blood test to confirm infection, determine stage, and track treatment response. It is widely used for STD screening, prenatal care, and early detection to prevent complications and transmission.

The Urinalysis Complete Test with Reflex to Culture screens urine for abnormalities in color, clarity, pH, protein, glucose, ketones, blood, and microscopic elements like red and white cells. If infection is suspected, it reflexes to a urine culture to identify bacteria. Doctors use this test to detect urinary tract infections (UTIs), kidney disease, diabetes, and metabolic disorders, guiding accurate diagnosis, treatment, and ongoing health management.